MDxHealth « Terug naar discussie overzicht

MDxHealth nieuws 2014

5.395 Posts, Pagina: « 1 2 3 4 5 6 ... 84 85 86 87 88 89 90 91 92 93 94 ... 266 267 268 269 270 » | Laatste
Pelikapuntzak
0
quote:

Bahassie schreef op 4 april 2014 17:14:

nog wat stukkies dr bij gedaan.........;-0
Je had beter even kunnen wachten en opvangen op €4.67. Scheelt weer 1%.
vreemdvermogen
0


IRVINE, Calif. and HERSTAL, Belgium, April 2, 2014 (GLOBE NEWSWIRE) -- MDxHealth SA (NYSE Euronext:MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to improve the diagnosis and treatment of cancer patients, today announced that it has entered into a co-marketing agreement with LI PATH (Long Island Pathology, Inc.) to promote MDxHealth's ConfirmMDx® for Prostate Cancer test. LI PATH is a high-end, full-service independent anatomic and clinical pathology laboratory that serves the New York City metropolitan area. The agreement expands MDxHealth's access to urologists in the highly populated New York and New Jersey region.

"Our goal is to be the premier laboratory serving the urology community in the New York City area, and offering the most advanced molecular testing to our urology clients is an important part of that equation," stated Ken Cerney, Chief Executive Officer of LI PATH. "The ConfirmMDx for Prostate Cancer test provides actionable information to help urologists better stratify patients at risk for undetected prostate cancer and guide the decision for repeat biopsy. The addition ConfirmMDx to our portfolio of tests enhances our ability to serve our clients."

"We are excited to announce our strategic partnership with LI PATH, recognized as a leading anatomic and clinical pathology laboratory in the New York metropolitan region. With their extensive client base and strong reputation, the partnership further expands access to our ConfirmMDx for Prostate Cancer test within this important geographic region," said Dr. Jan Groen, CEO of MDxHealth. "It is rewarding to partner with progressive thinking laboratory professionals like LI PATH, who are focused on leveraging molecular diagnostic tests to deliver the highest quality patient care."

Read more: www.nasdaq.com/press-release/mdxhealt...
[verwijderd]
0
Exact Science
13.66
+0.74 (5.73%)

Press Releases MDXhealth
April 2, 2014
MDxHealth and LI PATH Announce Marketing Agreement for ConfirmMDx for Prostate Cancer
Version Française
March 28, 2014
MDxHealth Licensee Exact Sciences Receives FDA Panel Recommendation for Approval of Colorectal Cancer Screening Test
Version Française
March 4, 2014
MDxHealth's PredictMDx for Glioblastoma Identifies Newly Diagnosed Patients with Improved Progression Free and Overall Survival
Version Française

We stonden voordat bovenstaande persberichten bekend werden over de 5 .

3 zeer goede persberichten later op 4,60 .het aandeel heeft een nieuwe bodemvorming gemaakt en winstnemers uitgeschut . Zodra het nieuws wat verder doordruppelt en er misschien wat meer analistenupdates/ volgers komen kan het volgende week de 5 definitief passeren . Zou mooi zijn als er een grote USA analist MDX gaat volgen/ aanbevelen . Tov USA biotech aandelen staat MDX koers zeer laag .

Een voorbeeld met een USA biotech is Horizon Pharma . Deze biotech stond 0,75 jaar geleden nog op 2 . Na bekend worden van toenemende verkopen en verkoopkanalen is het snel gestegen naar nu ruim 14 euro . Het heeft even geduurd voordat bij de Horizon beleggers doordrong dat het bedrijf aan het begin van een mooie ( oogst) periode is gekomen .

Zo zal het bij MDXhealth ook gaan lopen is mijn mening . Toenemende verkopen / verkoopkanalen . Toekomstige royaltiebetalingen van licentienemers + uitbreiding/ ontwikkeling van nieuwe testen .
Duidelijk LT aandeel op dit moment .
Pelikapuntzak
0
0.75 jaar is bij mij MLT. MDx heeft idd heel veel potentie en mochten ze in 9 maanden verzevenvoudigen dan is deze man (ver)koopman en mag iemand anders m'n aandeeltjes hebben.
Pelikapuntzak
0
Kom ik trouwens uit op plm. €35, een al vaker gehanteerd koersdoel. €4.66 zit in het vat en verzuurt niet want het wordt alleen maar meer.
[verwijderd]
0
Even voor de zaterdag avond gein, ik zoek voor mijn bedrijf de volgende functie:

Billing Collector
The Billing Collector is responsible for complete, timely, and accurate follow-up and collections on submitted claims to clients, commercial/government payers, and patients, to optimize overall reimbursement. Responsible for researching denials and rejections, settling payer issues, documenting account activity, posting adjustments, and demonstrating proficiency with the XIFIN billing system to ensure all functionalities are utilized for the most efficient processing and adjudication of claims. Responsible for identifying and reporting collection trends and/or issues resulting in delayed claims processing. Interacts with clients, insurance companies, patients, third-party payers, and company stakeholders, as necessary, to resolve account balances and provide the highest level of customer service. Responsible to maintain current on all private and government payer billing regulations and policies. Responsible for compliance to all applicable regulations, including but not limited to the Food and Drug Administration, ISO, and state and federal requirements.

Responsible for the collection activities of the company through continued and sustained contact with payers.
Proactively manages and resolves aged accounts or accounts with no activity in accordance with department/company metrics.
Responsible for helping with the development and implementation of collection strategies necessary to achieve operational cash flow objectives.
Identify and report trends and payer issues relating to billing and reimbursement.
Audit all Explanation of Benefits and ability to analyze payment postings and adjustments to ensure accuracy of reimbursement and proper adjustments have been applied.
Review denials and rejections and process the re-filing of the claim or submission of an appeal.
Effectively communicate with patients regarding their accounts, and provide financial assistance options based on their individual financial status.
Document all account activity and correspond to inquiries in a timely manner.
Comprehensive working knowledge of commercial and government payer regulations, guidelines, and requirements for billing and collections.
Communicates and works effectively with colleagues from other departments.
Follows written and verbal communications.
Follows all MDxHealth Inc.’s health and safety policies and procedures.
Performs other related duties as required or assigned.
[verwijderd]
0
quote:

tsete schreef op 7 april 2014 08:49:

de shorters zijn terug bezig (denk, ik)
Die moeten er ook ooit weer uit... Ik wacht het rustig af.
[verwijderd]
0
Ik ga er een aantal verkopen en arseus kopen (morgen 1ste kwartaal en het ziet er goed uit)
5.395 Posts, Pagina: « 1 2 3 4 5 6 ... 84 85 86 87 88 89 90 91 92 93 94 ... 266 267 268 269 270 » | Laatste
Aantal posts per pagina:  20 50 100 | Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met uw e-mailadres en wachtwoord.

Direct naar Forum

Detail

Vertraagd 1 jan 0001
Koers 0,000
Verschil 0,000 (0,00%)
Hoog 0,000
Laag 0,000
Volume 0
Volume gemiddeld 0
Volume gisteren 0